What are the options for cough suppressant medications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cough Suppressant Options

For chronic or acute bronchitis, use dextromethorphan 60 mg (not the standard 15-30 mg OTC dose) or peripheral cough suppressants like levodropropizine; for URI-related cough, avoid central suppressants and use ipratropium bromide instead; codeine offers no advantage over dextromethorphan and should be avoided due to its worse side effect profile. 1, 2

Treatment Algorithm by Cough Type

For Chronic or Acute Bronchitis

First-line options:

  • Dextromethorphan at 60 mg provides maximum cough reflex suppression (standard OTC doses of 15-30 mg are subtherapeutic) 2, 3
  • Peripheral cough suppressants (levodropropizine, moguisteine) are recommended for short-term symptomatic relief with substantial benefit 1
  • Ipratropium bromide (inhaled anticholinergic) is the only inhaled agent recommended for cough suppression 1

Second-line options:

  • Codeine can be used but offers no efficacy advantage over dextromethorphan while causing more drowsiness, nausea, constipation, and physical dependence 2, 3, 4
  • First-generation sedating antihistamines (like chlorpheniramine or promethazine) are particularly suitable for nocturnal cough due to sedative properties 2, 3

For Upper Respiratory Infection (URI/Common Cold)

Recommended:

  • Simple home remedies like honey and lemon may be as effective as pharmacological treatments and should be tried first 2, 3
  • Ipratropium bromide (inhaled) is the only recommended agent 1
  • Older antihistamine-decongestant combinations may provide benefit 1

NOT recommended:

  • Central cough suppressants (dextromethorphan, codeine) have limited efficacy for URI-related cough 1
  • Peripheral cough suppressants have limited efficacy for URI 1
  • Zinc preparations are not recommended 1
  • Most OTC combination cold medications lack proven efficacy 1

For Postinfectious Cough

Treatment sequence:

  • Try inhaled ipratropium first before central antitussives 2, 3
  • For severe paroxysms, consider prednisone 30-40 mg daily for a short period 2, 3
  • Central acting antitussives like dextromethorphan should only be considered when other measures fail 2, 3

Specific Agent Details

Dextromethorphan

  • Optimal dosing is 60 mg for maximum cough suppression (higher than typical OTC recommendations) 2, 3
  • Has superior safety profile compared to opioid alternatives 2, 3
  • FDA-approved as a cough suppressant 5
  • Should not be used for productive cough where secretion clearance is beneficial 2, 3
  • Caution: Some combined preparations contain other ingredients like acetaminophen at higher doses 2

Codeine

  • FDA-approved for cough due to minor throat and bronchial irritation 6
  • Not recommended as first-line due to adverse effects without superior efficacy 1, 2
  • Causes drowsiness, nausea, constipation, and risk of physical dependence 2

Ipratropium Bromide

  • The only inhaled anticholinergic recommended for cough suppression in URI or chronic bronchitis 1
  • Should be tried before central antitussives in postinfectious cough 2, 3

Menthol

  • Provides acute but short-lived cough suppression when inhaled 2, 3
  • Can be prescribed as menthol crystals or proprietary capsules 2

Agents NOT Recommended

  • Albuterol for acute or chronic cough not due to asthma 1
  • Mucolytics (agents altering mucus characteristics) for chronic bronchitis cough suppression 1
  • Drugs affecting the efferent limb of the cough reflex 1
  • Protussive pharmacologic agents in neuromuscular impairment 1

Common Pitfalls to Avoid

  • Using subtherapeutic doses of dextromethorphan (15-30 mg instead of 60 mg) that provide inadequate relief 2, 3
  • Prescribing codeine-based antitussives which have no efficacy advantage but increased side effects 2, 3
  • Using central cough suppressants for URI-related cough where they have limited efficacy 1
  • Applying cough suppressants to productive cough where secretion clearance is needed 2, 3
  • Overlooking simple non-pharmacological approaches like honey and lemon for benign viral cough 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Medications for Acute Cough in the Emergency Department

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cough Management with Dextromethorphan and Promethazine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.